Context Therapeutics Inc (CNTX)
1.39
-0.11
(-7.33%)
USD |
NASDAQ |
Nov 22, 09:45
Context Therapeutics Total Liabilities (Quarterly): 2.472M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.472M |
| June 30, 2024 | 1.604M |
| March 31, 2024 | 2.608M |
| December 31, 2023 | 4.192M |
| September 30, 2023 | 4.604M |
| June 30, 2023 | 3.757M |
| March 31, 2023 | 3.233M |
| December 31, 2022 | 3.208M |
| Date | Value |
|---|---|
| September 30, 2022 | 4.012M |
| June 30, 2022 | 3.048M |
| March 31, 2022 | 1.638M |
| December 31, 2021 | 3.033M |
| September 30, 2021 | 25.47M |
| June 30, 2021 | 25.02M |
| March 31, 2021 | 19.73M |
| December 31, 2020 | 17.39M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.604M
Minimum
Jun 2024
25.47M
Maximum
Sep 2021
7.814M
Average
3.495M
Median
Total Liabilities (Quarterly) Benchmarks
| Collegium Pharmaceutical Inc | 1.401B |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 86.33M |
| Shareholders Equity (Quarterly) | 83.86M |